JPRN-UMIN000021305
Recruiting
Phase 2
Phase II clinical trial of Gemcitabine and Nab-Pacritaxel combined therapy for pancreatic cancer with the difficulty of curative resection - Phase II clinical trial of Gemcitabine and Nab-Pacritaxel combined therapy for pancreatic cancer with the difficulty of curative resection
Department of Surgery, Tohoku University Graduate School of Medicine0 sites60 target enrollmentMarch 7, 2016
ConditionsPancreatic cancer
Overview
- Phase
- Phase 2
- Intervention
- Not specified
- Conditions
- Pancreatic cancer
- Sponsor
- Department of Surgery, Tohoku University Graduate School of Medicine
- Enrollment
- 60
- Status
- Recruiting
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- Not provided
Exclusion Criteria
- •(1\) not diagnosed as pancreatic duct adenocarcinoma (2\) recurrence (3\) obvious distant metastasis (4\) with prior anticancer therapy for pancreatic cancer (5\) with other active cancer (6\) with uncontrollable infection (7\) with hypersensitivity for pacritaxel or albmin (8\) pregnancy, postpartum within 28 days or lactating (9\) expected survival within 6 months (10\) difficult for out patient chemotherapy (11\) age \< 20 (12\) without judgement (13\) determined to be inappropriate as a subject
Outcomes
Primary Outcomes
Not specified
Similar Trials
Active, not recruiting
Phase 1
Phase I-II trial of gemcitabine plus nab-paclitaxel (GemBrax) followed by FOLFIRINOX as first-line treatment of patients with metastatic pancreatic adenocarcinoma - GABRINOXEUCTR2012-003678-13-FRInstitut Régional de Cancerologie de Montpellier - Val d’Aurelle118
Completed
Phase 2
Phase II study of Gemcitabine + nab-paclitaxel as first-line therapy for locally advanced pancreatic cancerlocally advanced unresectable pancreatic cancerJPRN-UMIN000016852Kurume university school of medicine24
Completed
Not Applicable
Phase I/II study of Gemcitabine plus nab-paclitaxel and intraperitoneal paclitaxel for pancreas cancer with peritoneal metastasisThe patients with pancreatic cancer who have peritoneal metastasis diagnosed by staging laparoscopy or open laparotomy.JPRN-UMIN000018878Study group of pancreatic cancer with peritoneal metastasis48
Completed
Phase 2
Phase II trial of the combination of gemcitabine and 131I-MIBG therapy in paediatric patients with relapsed or progressive neuroblastomaNL-OMON39557Academisch Medisch Centrum16
Active, not recruiting
Not Applicable
A phase II study of the combination of gemcitabine with 131I-MIBG therapy for children with neuroblastoma without other treatment options.relapsed or progressive neuroblastoma in pediatric patients of 1 to 18 yearsTherapeutic area: Diseases [C] - Cancer [C04]EUCTR2007-007974-45-NLAMC47